logo
14:39 May 02

Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
211.26
+0.21 (+0.10%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Piramal Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals 14:39 May 02
Up
211.26
+0.21 (+0.10%)
image/svg+xml

80/100 High Financial Strength

Quality
image/svg+xml

22/100 Expensive Valuation

Valuation

34/100 Technically Bearish

Technical

SWOT

Strength

5

Weakness

3

Opportunity

1

Threat

0

28.01K

Market Cap (Cr)

719.99

PE Ratio

3.54

Price to Book Ratio

43.1

RSI

0.21 %

Net Profit Margin

Rating Based on 6 Analysts

Buy 100%
Hold 0%
Sell 0%
Buy
The consensus recommendation from 6 analysts for Piramal Pharma Ltd. is Buy

Analyst Price Target

The average price target is 249.5 with a high estimate of 310 and low estimate of 176
Current 211.26
310.00
249.50
176.00
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation

SWOT

Checklist

12 11 0
  • Yes
  • No
  • Neutral

Financials

  • Company has seen consistent profit growth in the last eight quarters?
  • Company has seen consistent sales growth in the last eight quarters?
  • Company has high Trendlyne Durability Score?
  • Company has high Piotroski Score?
  • Company has Low Debt?
  • Shareholder Value: Company has Strong ROE?
  • Company has Positive Net Cash Flow?
  • Company is generating increasing cash from operations?

Ownership

  • FII/FPI or DIIs are buying the stock?
  • Promoters are buying the stock or ownership is stable?
  • Promoter pledge is low and not increasing?
  • Insiders have not sold stock in the past 3 months?

Peer Comparison

  • Company is giving better long term returns than the industry?
  • Company's sales growth is better than the industry median?
  • Company's profit growth is better than the industry median?

Value And Momentum

  • The stock is in the Buy Zone according to its historical P/E?
  • The stock is in the Buy Zone according to its historical P/BV?
  • Company's valuation score signals overall affordability?
  • Trendlyne Momentum Score shows bullishness?
  • Stock is trading above all short term SMAs?
  • Stock is trading above all long term SMAs?
  • Stock has bullish candlesticks?
  • Stock has active positive breakouts?

Checklist

12 11 0
  • Yes
  • No
  • Neutral

Financials

  • Company has seen consistent profit growth in the last eight quarters?
  • Company has seen consistent sales growth in the last eight quarters?
  • Company has high Trendlyne Durability Score?
  • Company has high Piotroski Score?
  • Company has Low Debt?
  • Shareholder Value: Company has Strong ROE?
  • Company has Positive Net Cash Flow?
  • Company is generating increasing cash from operations?

Ownership

  • FII/FPI or DIIs are buying the stock?
  • Promoters are buying the stock or ownership is stable?
  • Promoter pledge is low and not increasing?
  • Insiders have not sold stock in the past 3 months?

Peer Comparison

  • Company is giving better long term returns than the industry?
  • Company's sales growth is better than the industry median?
  • Company's profit growth is better than the industry median?

Value And Momentum

  • The stock is in the Buy Zone according to its historical P/E?
  • The stock is in the Buy Zone according to its historical P/BV?
  • Company's valuation score signals overall affordability?
  • Trendlyne Momentum Score shows bullishness?
  • Stock is trading above all short term SMAs?
  • Stock is trading above all long term SMAs?
  • Stock has bullish candlesticks?
  • Stock has active positive breakouts?
Research 360 logo

Download Our App On:

SunMonTueWedThuFriSat
2627282930311234567891011121314151617181920212223242526272829303112345